Hormones, metabolism and body composition as major determinants of blood rheology: Potential pathophysiological meaning

Clinical Hemorheology and Microcirculation

Volumn 26, Issue 2, 2002, Pages 63-79

  Brun, J F ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Blood viscosity; Erythrocyte aggregability; Erythrocyte deformability; Fibrinogen; Growth hormone; Hemorheology; Hormones; Insulin; Insulin sensitivity; Metabolism; Plasma viscosity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCIUM; CARRIER PROTEIN; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ERYTHROPOIETIN; FATTY ACID; GROWTH HORMONE; HORMONE; INSULIN; INTERLEUKIN 6; KETONE; LACTIC ACID; LEPTIN; MAGNESIUM; NITRIC OXIDE; NORADRENALIN; PLASMA PROTEIN; SOMATOMEDIN; ZINC;

ADIPOSE TISSUE; ADRENAL GLAND; BIOACCUMULATION; BLOOD CELL; BLOOD RHEOLOGY; BODY COMPOSITION; CANCER; CONFERENCE PAPER; ENDOCRINE FUNCTION; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEMODYNAMICS; HORMONE METABOLISM; HUMAN; INSULIN SENSITIVITY; METABOLISM; MICROCIRCULATION; NONHUMAN; OSMOLALITY; OXIDATIVE STRESS; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PLASMA CELL; PLASMA VISCOSITY; PROTEIN SECRETION; REGULATORY MECHANISM; BLOOD; BLOOD VISCOSITY; DRUG EFFECT; HEMATOLOGIC DISEASE; PHYSIOLOGY; PLASMA; REVIEW;

BLOOD CELLS; BLOOD VISCOSITY; BODY COMPOSITION; HEMATOLOGIC DISEASES; HEMORHEOLOGY; HORMONES; HUMANS; PLASMA;

EID: 0036109202     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (158)

1. Red blood cell aggregation and microcirculation in rat cremaster muscle
2. Relationships between blood rheology and transcutaneous oxygen pressure in peripheral occlusive arterial disease
3. Blood flow structure related to red cell flow: A determinant of blood fluidity in narrow microvessels
4. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
5. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Heart Disease studies
6. The possible role of hemorheology in atherothrombogenesis
7. Impaired blood rheology: A risk factor after stroke?
8. Facteurs physico-chimiques de la filtrabilité érythrocytaire
9. Acid-base balance and aggregation properties of erythrocytes
10. Effect of plasma osmolality on erythrocyte aggregation index
11. Shear dependent interaction of plasma proteins with erythrocytes in blood rheology
12. Physicochemical basis and clinical implications of red cell aggregation
13. Influence des protéines plasmatiques sur l'agrégation érythrocytaire
14. Effects of fibrinogen, globulin, albumin and hematocrit on the kinetics of erythrocyte aggregation in man
15. Microrheology and protein chemistry of pathologic red cell aggregation (blood sludge) studied in vitro
16. Fibrinogen-induced erythrocyte aggregation: Erythrocyte-binding site on the fibrinogen molecule
17. Opposite effects of albumin on the erythrocyte aggregation induced by immunoglobin G and fibrinogen
18. Associations between plasma viscosity and lipids/apoproteins. Results from the MONICA-project Augsburg
19. Opposite effects of low-density and high-density lipoprotein on blood viscosity in fasting subjects
20. Les acides gras phospholipidiques membranaires au cours de l'effort physique de longue durée avec ou sans apport nutritionnel d'huiles de poissons
21. Influence of polyunsaturated fatty acid diet on the hemorheological response to physical exercise in hypoxia
22. Hemorheological and hemodynamical effects of fish oil (Ameu) in patients with ischemic heart disease and hyperlipoproteinemia
23. Haemorheological changes during postprandial lipemia
24. Aachen study: Dependence of plasma viscosity on plasma proteins and lipids
25. Determinants of plasma viscosity in primary hyperlipoproteinemias
26. A calcium antagonisdtic effect of magnesium related to erythrocyte deformability
27. In vitro influence of zinc and magnesium on the deformability of red blood cells artificially hardened by heating
28. Zinc salts improve in vitro erythrocyte flexibility
29. Serum zinc and blood rheology in sportsmen (football players)
30. Effects of supplementation on blood rheology during exercise
31. In vitro effects of zinc gluconate and acetate on red cell aggregability
32. Assessing Iron status of a population
33. The study on RBC deformability of iron deficiency anemia
34. Effects of iron-copper free diet on whole blood filtrability in rats
35. Increased blood viscosity in iron-depleted elite athletes
36. Iron-induced oxidative damage in human red blood cells and the effect of thiol-containing antioxidants
37. Short term in vitro influence of different glucose and insulin levels on red blood cell filterability
38. Effect of glucose and galactose on RBC deformability
39. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus
40. Blood viscosity in diabetic patients
41. Reduced erythrocyte deformability in diabetes
42. Red cell aggregation and red cell deformability in diabetes
43. Erythrocyte deformability and diabetes
44. Erythrocyte rheology in diabetes
45. Only marginal influence of metabolic control on blood rheology in insulin-dependent diabetic patient without manifest angiopathy
46. In vitro assessment of "covertly" abnormal blood rheology: Critical appraisal of presently available microrheological methodology. A review focusing on diabetic retinopathy as a possible consequence of rheological occlusion
47. Haemorheological consequences of hyperglycemic spike in healthy volunteers and insulin-dependent diabetics
48. Influence of lactate on the insulin action on red blood cell filterability
49. Influence of circulating lactate on blood rheology during exercise in professional football players
50. Opposite effects of in vitro lactate on erythrocyte deformability and aggregability in sedentary subjects vs athletes
51. Red cell rigidity paradoxically decreases during maximal exercise in endurance athletes unless they are prone to exercise-induced hypoxaemia
52. Hemorheologic effects of a short-term ketogenetic diet
53. Blood doping: A literature review
54. Effect of erythropoietin administration on maximal aerobic power in man
55. The efficacy of ergogenic agents in athletic competition. Part II, Other performance-enhancing agents
56. Other ergogenic agents
57. Better dead than second
58. Sports haematology
59. Effects of recombinant human erythropoietin therapy in red cell filterability and membrane lipid composition from haemodialysis patients
60. Evolution of hemorheological parameters in dialyzed chronic renal failure patients after erythropoietin treatment or renal transplantation
61. Rheological effects induced by erythropoietin (r-HuEPO) treatment
62. Filtrabilité des hématies chez les diabétiques: Influence de la glycémie et correction aprés connexion à un pancréas artificiel
63. Lack of acute effects of insulin in vivo on hemorheological parameters in hyperglycemic diabetic patients
64. Insulin has no influence in vitro on hemorheological parameters measured in poorly controlled diabetic patients
65. Relations between molecular rheology and red blood cell structure, methods and clinical approaches
66. Effects of insulin on human erythrocyte membrane fluidity in diabetes mellitus
67. In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetes
68. Erythrocyte deformability is related to fasting insulin and declines during euglycaemic hyperinsulinaemia in hypertensive patients
69. La déformabilité érythrocytaire est réduite par le glucagon
70. Evidence for the hormonal status of somatostatin in man
71. Somatostatin and peripheral blood flow in man
72. Different effects of three kinds of somatostatin (15-28, 1-14, 1-28) on rabbit's platelet aggregation
73. In vitro effects of somatostatin on red cell filterability measured by three methods
74. Microvascular effects of human proinsulin C-peptide in diabetes mellitus type 1
75. In vitro effect of norepinephrine and isoprenaline on erythrocyte filterability under pathologic conditions
76. The effect of adrenaline upon human erythrocyte. Sex-related differences?
77. Effect of two arachidonic acid metabolites of white blood cells on red blood cell filterability studied by cell transit-time analysis
78. Leukotriene B4 decreases red cell deformability as assessed by increased filtration index
79. Effects of aprostadil (PGE1) on red and white cell deformability during cardiopulmonary bypass
80. Hemorheological actions of the prostaglandins D2, E1, E2, F1a, F2a and Iloprost
81. Aspects hémorhéologiques de l'activation leucoplaquettaire dans les pathologies athéromateuses, applications cliniques
82. Nitric oxide in atherosclerosis: Vascular protector or villain?
83. Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro
84. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats
85. Red blood cell rheology in L-NAME-induced hypertension
86. Endothelin, microcirculation and hemorheology
87. In vitro influence of nitrovasodilators and endothelin-1 on rheology of human blood
88. Influence of parathyroid hormone, calcitonin, cholecalciferol, calcium and calcium ionophore A23187 on erythrocyte morphology and blood viscosity
89. Effect of oral contraceptives on blood viscosity
90. Increased blood viscosity in young women using oral contraceptives
91. Increased blood viscosity in young women taking oral contraceptives
92. Altered haemorheology in oral-contraceptive users
93. Oral contraceptives, blood clotting and thrombosis
94. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity
95. Rheological studies in obstetrics and gynaecology
96. Influence of sex hormones on blood rheology and plasma protein pattern during the menstrual cycle
97. Haemorheological consequences of oestrogen and progestogen therapy
98. Influence of oral contraceptives on blood rheology and hemostatic and metabolic patterns in young women. Results of a three year study
99. Hemorheological effects of oral contraceptives
100. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives
101. Effects of estrogen on the endothelium in postmenopausal women: Implications for atherosclerosis
102. Menopause-related change in plasma viscosity
103. Hemorheological changes at menopause
104. Hormonal substitution therapy effect in the hemorheological profile of post-menopausal women
105. Rheological characteristics of blood through the menstrual cycle
106. Gender, menstrual cycle, oral contraceptives and red blood cell deformability in healthy adult subjects
107. Blood rheology and red cell metabolism in the menstral cycle in the menstrual cycle in normal and heterozigous thalassemic women
108. Blood viscosity in the diabetic patient with retinopathy versus hematocrit: Is it a compensatory mechanism?
109. Hematocrit in type 1 diabetics
110. Red cell filterability in preeclamptic versus normal pregnant women and in their newborns
111. Increased plasma viscosity as a reason for inappropriate erythropoietin formation
112. Shear stress modulates erythropoietin secretion and explains unexpectedly low erythropoietin levels
113. Haemorheology and the inflammatory process
114. Aspects hémorhéologiques de l'activation leucoplaquettaire dans les pathologies athéromateuses: Applications cliniques
115. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study
116. Activated polymorphonuclear leukocytes affect red blood cell aggregability
117. Effect of superoxide ions on red blood cell rheologic properties
118. Influence of a videofilm-induced emotional stress on the flow properties of blood
119. Modifications hémorhéologiques au cours du stress, des maladies mentales et des troubles de l'humeur
120. Vascular reactivity
121. Adipose tissue: An endocrine organ?
122. Endocrine/paracrine factors produced by adipocytes
123. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects
124. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
125. Relationships between metabolic and hemorheologic modifications associated with overweight
126. Relationships among body composition, hemorheology and exercise performance in rugbymen
127. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
128. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
129. Leptin stimulates rat aortic smooth muscle cell proliferation and migration
130. Correlation between plasma viscosity, erythrocyte disaggregability and leptin
131. Is the growth-hormone-insulin-like growth factor 1 (GH-IGF-I) axis a physiological regulator of blood rheology?
132. Elevated fibrinogen levels decrease following treatment of acromegaly
133. Hemorheology of growth hormone-deficient adults
134. Exercise-induced growth hormone secretion and hemorheology during exercise in elite athletes
135. Relationships between blood viscosity and insulin-like growth factor I status in sportsmen
136. Insulin-like growth factor-binding protein one and blood rheology in athletes
137. Thrombosis and hemorheology in patients with breast cancer and adjuvant therapy
138. Alterations in the clotting system and hemorheology in gynecologic malignancies
139. Aggregability and disaggregability of erythrocytes in women suffering from ovarian cancer: Evidence for an increased disaggregation threshold
140. Hemorheological profiles in cancer patients
141. Application of plasma viscosity to assess the status of cancer patients
142. Blood rheology in patients with gastric cancer
143. Prognostication of complications in surgery of lung cancer
144. Blood rheology during chemotherapy in patients with ovarian cancer
145. La resistance a l'insuline: Du diagnostic clinique a la genetique moleculaire. Implications dans le diabete sucre
146. The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
147. Hormone and substrate modulation of plasma triglyceride concentration in primary hypertriglyceridemia
148. Negative correlation between plasma fibrinogen and insulin sensitivity measured with the minimal model technique
149. Association between plasma fibrinogen levels and and insulin resistance
150. Relationships between fibrinogen and insulin resistance
151. La viscosité sanguine est corrélée à l'insulino-résistance
152. Multivariate analysis of relationships between insulin sensitivity and blood rheology
153. Blood viscosity is negatively correlated to insulin sensitivity
154. Relationships between insulin resistance measured with the minimal model and blood rheology: A multivariate analysis
155. Regular exercise (3×45 min/wk) decreases plasma viscosity in sedentary obese, insulin resistant patients parallel to an improvement in fitness and a shift in substrate oxidation balance
156. Regular exercise decreases plasma viscosity in sedentary obese, insulin resistant patients parallel to an improvement in fitness and a shift in substrate oxidation balance